A Mayo Clinic-led international phase 3 study found that a new immunotherapy helped many patients with an aggressive form of bladder cancer keep their bladder instead of having it surgically removed.

A new treatment combination - Keytruda plus Padcev - is now approved for use before and after bladder‑removal surgery, offering a more effective option for many patients.

The US Food and Drug Administration has approved Johnson & Johnson’s drug delivery system for a type of bladder cancer, offering a potential surgery-free option for patients. The drug release system, ...

Enfortumab vedotin plus pembrolizumab significantly improves EFS and OS in cisplatin-ineligible MIBC patients, offering a new treatment option. The EV-303 trial is the first to show systemic treatment ...

PHOENIX - A Mayo Clinic-led international phase 3 study found that a new immunotherapy helped many patients with an ...

Surgery for advanced bladder cancer includes transurethral resection of the bladder tumor (TURBT) to remove tumors and cystectomy to remove all or part of the bladder, with the choice depending on the ...

When a warrior returns from battle, the sharing of the story is the final act of the campaign. It brings the soldier home.

Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that the U.S. Food and Drug Administration (FDA) has approved PADCEV® ...

Tackling bladder cancer requires expertise in biology, chemistry, imaging, mathematics and clinical practice working together. PHIRE is not simply a technical development; it reflects a way of working ...

Colorado football coach Deion Sanders was diagnosed with an aggressive form of bladder cancer earlier this year, had surgery to remove the organ and is now considered cured by his doctors, the Pro ...